Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 2,164
Change Today 0.00 / 0.00%
Volume 0.0
INTP On Other Exchanges
Tel Aviv
As of 10:24 AM 08/27/15 All times are local (Market data is delayed by at least 15 minutes).

intec pharma ltd (INTP) Snapshot

Previous Close
Day High
Day Low
52 Week High
10/28/14 - $3,695
52 Week Low
12/29/14 - $1,750
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for INTEC PHARMA LTD (INTP)

Related News

No related news articles were found.

intec pharma ltd (INTP) Related Businessweek News

No Related Businessweek News Found

intec pharma ltd (INTP) Details

Intec Pharma Ltd., a drug development company, develops formulations of drugs using its proprietary gastric retention technology, the Accordion Pill, in Israel. The Accordion Pill, a novel gastro-retentive delivery system improves the pharmacokinetics and pharmacodynamics of various drugs. The company is focusing on the clinical development program for the Phase III clinical study of the Accordion Pill Carbidopa Levodopa (AP-CDLD), for the treatment of advanced stages Parkinson’s disease patients. Its pipeline also comprises The Accordion Pill – Zaleplon, a drug for sleep onset, which is in Phase II clinical program. Intec Pharma Ltd. is based in Jerusalem, Israel.

44 Employees
Last Reported Date: 07/16/15

intec pharma ltd (INTP) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: 764.0K
Co-Founder and Chairman
Total Annual Compensation: 767.5K
Chief Financial Officer
Total Annual Compensation: --
Executive Vice President of Research & Develo...
Total Annual Compensation: 758.6K
Vice President of Business Development and Cl...
Total Annual Compensation: 646.5K
Compensation as of Fiscal Year 2014.

intec pharma ltd (INTP) Key Developments

Intec Pharma Ltd.(NasdaqCM:NTEC) added to NASDAQ Composite Index

Intec Pharma Ltd. has been added to Nasdaq Composite Index.

Intec Pharma Ltd., Special/Extraordinary Shareholders Meeting, Jul 16, 2015

Intec Pharma Ltd., Special/Extraordinary Shareholders Meeting, Jul 16, 2015., at 11:00 Israel Standard Time.

Intec Pharma Forms Drug Development Partnership with Unnamed Pharma Company

Intec Pharma has announced the signing of a development and licensing agreement with an unnamed international pharmaceutical company. The agreement involves Intec undertaking research examining the potential to incorporate its Accordion Pill technology with a novel drug marketed by the international pharmaceutical company. Research will be funded by the pharmaceutical company, which also retains the option to commercialise any related product. The financial terms of the deal include USD 250,000 in upfront payments, with USD 670,000 subject to research milestones. Further payments of USD 8 million and USD 39 million would be made should the option of later-stage clinical development be exercised and relevant development milestones related to this be reached. Should a product reach market, Intec would receive low single-digit royalties up to USD 25 million annually or USD 100 million over the product's life cycle. A copy of Intec's press release detailing the deal can be accessed here.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
INTP:IT 2,164.00 0.00

INTP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for INTP.
View Industry Companies

Industry Analysis


Industry Average

Valuation INTP Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INTEC PHARMA LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at